• Clearmind Medicine notified investors on October 16, 2026, of a $2 million convertible promissory note issuance under its existing $10 million program.
• The notes will generate $1.8 million in cash proceeds at 90% of principal value.
• Closing is expected on or before October 19, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-110220), on October 16, 2026, and is solely responsible for the information contained therein.